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stimulants was started (filgrastim, 480/xg intravenously, 
and sargramostim, 500/xg intravenous piggyback every 
12 hours). On POD 37, further debridement and recon- 
struction of the sternum with omental transfer and 
split-thickness skin grafting were done. 
The remainder of the hospital course was marked by 
extensive surgical wound care, steroid therapy, intermit- 
tent dialysis, chemical bone marrow stimulation, nutri- 
tional support, and physical rehabilitation. The patient 
was transferred to a rehabilitation center on POD 72. At 
hospital discharge, the white blood cell count was 9.6 
K/UL, hemoglobin and hematocrit values were 7.0 gm/dl 
and 21.6%, and platelet count was 15 K/UL. 
Discussion. Pyoderma gangrenosum is a rare disorder 
and only two case reports document the disease after coro- 
nary artery bypass grafting procedures. 1'2 The cause of 
pyoderma gangrenosum is unknown. It is, however, immu- 
nologic in nature. 3 Characteristically, the lesions are found 
after an injury to the skin. 2 There are no organisms found on 
Gram stain tests and there is no growth on culture. Typically, 
there are ulcerations marked by well-defined borders with a 
blue outline indicating necrosis of the subcutaneous ti sue. 
Although the diagnosis of pyoderma gangrenosum is clinical, 
there are characteristic histopathologic features: acute and 
chronic inflammatory changes, endothelial proliferation, loss 
of the epidermis at the ulcerated sites, and epidermal 
hyperplasia at the borders. 
In our case and in another previously described, 4 pyo- 
derma gangrenosum was linked to  myeloproliferative 
disease. In the report of Romano and Safai, 4 the patient 
was known to have chronic myelocytic leukemia. In that 
case, the skin lesions responded to a course of oral 
prednisone beginning with 80 mg per day. 4 In our case, the 
disease was discovered uring the evaluation of pancyto- 
penia. This delay in diagnosis resulted in further skin and 
subcutaneous necrosis that necessitated extensive de- 
bridement. Once the diagnosis was made, steroid therapy 
arrested the necrotic process and reversed the cutaneous 
pathologic hanges. In a similar case, cyclosporine A (5 
mg/kg) was successfully used to avoid the wound-healing 
problems associated with steroid use. 2 In our case, the use 
of cyclosporine was not an option because of the chronic 
renal failure and pancytopenia. 
The challenging component of our case was the preven- 
tion of sepsis in the setting of pancytopenia with extensive 
open Surgical wounds. Broad-spectrum antibiotic over- 
age, strict isolation, frequent surveillance cultures, and 
pharmacologic stimulation of the bone marrow were 
necessary. Despite these steps, various local infections 
occurred, including dialysis access-related infection and 
upper respiratory tract infection. Fortunately, systemic 
involvement was avoided. 
In conclusion, concurrent pyoderma gangrenosum and 
myeloproiiferative disease represents a unique and challeng- 
ing clinical problem. Early recognition of the skin manifes- 
tations of pyoderma gangrenosum is necessary so that ste- 
roid therapy can be instituted, thereby avoiding radical 
debridement of wounds. The therapy for the associated 
pancytopenia requires support of the bone marrow with 
chemical stimulants. Prophylactic broad-spectrum antibiotic 
coverage is necessary to prevent sepsis. 
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Supraventricular tachyarrhythmia (SVT) , mainly in the 
form of atrial fibrillation (AF), occurs in up to 40% of 
patients undergoing coronary artery bypass grafting 
(CABG) and although usually benign can cause hemody- 
namic instability, prolong hospital stay and increase costs, 
and, rarely, predispose to a cerebrovascular accident. 1 
Pericardial effusions are incriminated in the develop- 
ment of SVT after CABG9 Posterior pericardiotomy has 
recently been reported to reduce the incidence of echo- 
cardiographically defined pericardial effusions from 40% 
in a control group to 8% in a pericardiotomy group with 
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Table I. Demographic, preoperative, and intraoperative characteristics of the two groups 
Control group Pericardiotomy group p Value 
No. 50 50 NS 
Mean age (yr) 61 (2) 61 (9) NS 
LV function 
Good 32 38 NS 
Moderate 12 10 NS 
Poor 6 2 NS 
Preop. beta blockers 34 28 NS 
Risk factors 
Diabetes 5 10 NS 
Hypercholesterolemia 23 25 NS 
Smoking 25 26 NS 
Hypertension 19 10 NS 
No. of grafts 2.7 (0.7) 2.7 (0.6) NS 
Type of arterial grafts 
Left internal thoracic 47 48 NS 
Radial 18 22 NS 
Endarterectomy 7 3 NS 
Ischemic time (min) 33 (8) 35 (2) NS 
CPB time (min) 62 (17) 66 (17) NS 
Numbers inparentheses arethe standard deviation. NS, Not significant; CPB, cardiopulmonary bypass. 
Table II. Postoperative data in the two groups 
Control group Pericardiotomy group p Value 
No. 50 50 
Ventilation time (hr) 7 (4) 7 (7) 
Blood loss (ml) 
At 12 hr 660 (238) 831 (303) <0.01 
Total 813 (282) 1032 (367) <0.001 
Arrhythmias (n) 
AF 9 12 
Other 1 1 
Total 10 13 
IABP 1 1 
Death 1 1 
IABP, Intraaortic balloon pump. 
a simultaneous reduction in the incidence of SVT from 
36% to 8%. 3 That study was not, however, strictly ran- 
domized and neither the number of participating surgeons 
nor their method or methods of myocardial protection 
was specified. 
In a prospective, randomized trial we tested the hypoth- 
esis that posterior pericardiotomy reduces the postopera- 
tive incidence of SVT by improving pericardial drainage. 
Methods. One hundred consecutive patients undergo- 
ing isolated first-time CABG by one surgeon (D: P. T.) 
were randomized to receive posterior pericardiotomy or
no posterior pericardiotomy (control group). Patients with 
unstable angina Were included and left ventricular (LV) 
function was assessed at cardiac catheterization a d de- 
fined as good (ejection fraction >50%), moderate (ejec- 
tion fraction 30% to 50%), or poor (ejection fraction 
<30%). 
Operation, All operations were done with the use of 
intermittent global ischemia with the systemic tempera- 
ture allowed to drift to 34 ° C. Cardiopulmonary b pass 
was established with a roller pump and nonpulsatile flow 
between 2.0 and 2.4 L .  m ' min. A Cobe CML membrane 
oxygenator and alpha-stat arterial carbon dioxide tension 
management were used and arterial pressure maintained 
at 50 to 80 mm Hg. 
Pericardiotomy. Patients randomized tothe pericardiot- 
omy group received a 4 cm posterior pericardial incision 
below the left inferior pulmonary vein parallel and poste- 
rior to the phrenic nerve as described by Mulay and 
colleagues? 
Drainage. Anterior mediastinal nd left pleural drains 
were routinely placed with suction at 10 mm Hg. Hourly 
blood loss was recorded until drain removal the following 
day. 
Postoperative lectrocardiography. The electrocardio- 
gram (ECG) was monitored continuously for the first 48 
hours after operation and subsequently b 12-lead ECGs 
as required. In the event of SVT the serum potassium 
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level was corrected if less than 4.5 mmol/L. If the SVT 
persisted sotalol or digoxin administration was begun 
depending on LV function. 
Statistics. The analysis of the data was done with SPSS 
software. Clinical data are expressed as the mean plus or 
minus the standard eviation. Differences were analyzed 
with a t test or a Mann-Whitney test for nonparametric 
data. The differences were considered to be significant for 
p values <0.05. 
Results. The groups were well matched with regard to 
age, sex, medications received (particularly beta blockers), 
LV function, and unstable angina necessitating adminis- 
tration of intravenous heparin and nitrates (Table I). The 
groups were similar with respect o the number of grafts 
(including the use of internal thoracic and radial artery 
grafts), ischemic time, and cardiopulmonary b pass time 
(Table I). 
Postoperative factors. There was one hospital death in 
each group in patients with severely impaired LV func- 
tion. One patient underwent reoperation because of 
bleeding from a side branch of the internal thoracic artery. 
One patient in each group required insertion of an 
intraaortic balloon pump but both patients recovered and 
were discharged from the hospital. The groups were 
similar with regard to duration of mechanical ventilation. 
Incidence of SIZE. There was no significant difference 
between the two groups with respect o the incidence of 
SVT or AF, which occurred in 13 patients (26%) in the 
pericardiotomy group and in 10 patients (20%) in the 
control group (Table II). In the two groups the combined 
incidence of SVT was 5 patients of 45 patients younger 
than 60 years old and 18 of 55 patients older than 60 years 
(p < 0.01). 
Chest drainage. The fenestration group had significantly 
greater chest drainage at 12 hours (831 _+ 303 ml vs 660 +_ 
238 ml) and in total (1032 _+ 367 ml vs 813 + 282 ml) 
compared with values in the control group (Table II). 
Discussion. The cause of postoperative SVT is not 
entirely clear. In a study of 1666 patients undergoing 
isolated CABG the overall incidence of AF was 28%, with 
the major occurrence 2 days after the operation. 4 Univar- 
late and multivariate analyses identified increased patient 
age to be the dominant factor promoting AF and multi- 
variate analysis showed that postoperative beta-blocker 
therapy conveyed considerable protection against AF 
(p = 0.001) but was less effective in older patients. 4 
Pericardial effusion has also been implicated in the 
development ofAF, 2 and Mulay and colleagues 3 reported 
a dramatic reduction in the incidence of pericardial 
effusions and SVT with a posterior pericardial incision. 
Their findings were, however, weakened by nonrandom- 
ization of the patients and failure to describe ither the 
number of surgeons involved or the method or methods of 
myocardial protection used. 
In our study prospective randomization and the fact 
that all operations were done by one surgeon resulted in 
two similar groups with respect o preoperative, intraop- 
erative, and postoperative factors. The incidence of SVT 
was not statistically different in the two groups and 
occurred in 10 patients (20%) in the control group and 13 
(26%) in the fenestration group. The overall incidence of 
SVT of 23% is similar to the 19% incidence previously 
reported from this unit also with the use of intermittent 
global ischemia. 5 The observation that increased age may 
be the most important factor for the development ofAF is 
supported in the current study. In the two groups com- 
bined the incidence of SVT was 5 patients of 45 patients 
younger than 60 years old and 18 of 55 patients older than 
60 years (p < 0.01). 
Our study demonstrated a significantly greater pleural 
drainage in the posterior pericardiotomy group both at 12 
hours and in total, which implies that this does result in 
more effective pericardial drainage but does not reduce 
the incidence of AF. It is unlikely that increased rainage 
was the result of bleeding from the pericardial incision 
because the edges were cauterized and specifically 
checked for bleeding. 
There are two potential limitations of our study. First, 
we did not perform continuous ECG monitoring after 48 
hours unless there was clinical suspicion of cardiac ar- 
rhythmia. The aim of our study was, however, only to 
detect persistent "clinically relevant" AF that would ne- 
cessitate medication. Second, we did not perform echo- 
cardiography to quantify the incidence or size of any 
pericardial effusions. Mulay and colleagues 3 used echo- 
cardiography to confirm pericardial effusions in 8% of 
patients with a posterior pericardiotomy and in 40% of 
control patients (p < 0.001) and concluded that pericar- 
diotomy reduced the incidence of pericardial effusions 
and SVT. Although the increased chest drainage in the 
posterior pericardiotomy group confirms that this maneu- 
ver results in more effective pericardial drainage, poste- 
rior pericardiotomy does not reduce the incidence of SVT 
and is not associated with any other difference in outcome. 
Unless clinical benefit of improved pericardial drainage is 
confirmed the routine performance of posterior pericar- 
diotomy cannot be recommended. 
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